John Sorenson, Ph.D. - Director and CEO/President of Vestaron (former)
Former President, Syngenta Biotechnology
Elin Miller - Vice Chairman
Keith Gillard - Chairman of the Board of Directors
General Partner, Pangaea Ventures, Ltd.
Ronald Meeusen - Director
Managing Partner, Cultivian Sandbox Ventures
James Schultz - Director
Managing Partner, Open Prairie Ventures
Not shown in the picture:
Mark Wong - Director
Serial energy and agriculture entrepreneur
Anna Rath - President and CEO
Robert M. Kennedy, Ph.D. – CSO
With over 25 years of research management experience, Bob leads Vestaron’s molecular biology and chemistry development teams. Management positions in Fortune 500 companies (Pfizer), academic appointments (Columbia, Michigan) and start-ups add to the leadership and technical experience he brings to Vestaron’s Research and Development success.
Nancy K. Newman – CFO
25 years of finance, tax, treasury and systems experience with Fortune 500 and start-up companies, leading finance efforts in formation and oversight of global operations as well as leadership in developing corporate financing strategies. Her experience includes Pharmacia/Upjohn, Pfizer, Interpublic Group of Companies, A.M. Todd Group and several early stage companies.
Andy Renz – Vice President of Business Development
Over 15 years of industry experience in agricultural innovation and business development. Andy held management positions at BASF, was Vice President of Business Development at Benson Hill Biosystems, and is on the industry advisory board of ag tech start-up’s, incubators and conferences. He has a strong network in agricultural solutions and is an expert in international negotiations.